Sterling to receive TFT arrays from OIS

Article

Sterling Diagnostic Imaging has announced that a supply of thin-film transistor (TFT) arrays for its iiRad with DirectRay digital x-ray systems has been assured into the second quarter of 1999. The Greenville, SC-based company reached a settlement with

Sterling Diagnostic Imaging has announced that a supply of thin-film transistor (TFT) arrays for its iiRad with DirectRay digital x-ray systems has been assured into the second quarter of 1999. The Greenville, SC-based company reached a settlement with OIS (Optical Imaging Systems) that will enable Sterling to gain access to all the TFT arrays at OIS, which recently announced it had shut its doors when its primary investor withdrew funding (SCAN 10/14/98). Sterling will also receive work-in-progress arrays from OIS, according to Sterling.

Meanwhile, the company is having encouraging discussions with several alternative TFT suppliers that could result in resumed production of TFT panels for Sterling by mid-1999, said Ernest Waaser, COO. This would result in minimal impact on supply of iiRad with DirectRay systems, he said.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.